However, another study done by Lao et al [30] on women with stage I–III breast cancer patients aged 44–55 years old demonstrated that menopausal patients with ER+ and/or PR + subtypes have a higher risk for metastatic relapse at an HR of 1.38. Here, PGR is linked to breast carcinoma.